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Abstract  
 
The World Health Organization-Composite International Diagnostic Interview (WHO-CIDI) 
is a highly structured interview for the assessment of mental disorders, based on the 
definitions and criteria of the fourth edition of the American Psychiatric Association’s 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Over the past decade it has 
become evident that the CIDI does not sufficiently address the assessment needs of women. 
Women are affected by most mental disorders, particularly mood and anxiety disorders, 
approximately twice as frequently as men. Women-specific disorders, such as Premenstrual 
Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), psychiatric disorders during 
pregnancy and postpartum as well as during the perimenopause, menopause and beyond are 
not addressed by the standard CIDI diagnostic modules. In addition, the CIDI in its current 
form does not address the potential effect that female reproductive milestones may have on 
diagnosis, treatment and prevention of mental disorders in women. Our aim was to develop a 
new women specific platform (CIDI-VENUS; CIDI-V) to be embedded in the existing CIDI 
that will address the above mentioned current deficiencies. Guided by a team of experts in the 
field of Women’s Mental Health from Canada and Germany the following modules were 
developed: 1) A complete menstrual history and comprehensive contraceptive history with a 
link to the Premenstrual Symptoms Screening Tool (PSST). 2) A complete perinatal history of 
pregnancies, miscarriages, terminations, still births, death of a child, with details of current 
pregnancy including gestation and expected date of confinement, labour history and 
breastfeeding, history of tobacco, alcohol, and other substance use including prescription 
drugs during pregnancy and postpartum, a section on specific phobias and on recurrent 
obsessive/ compulsive thoughts/behaviours (OCD) related to the baby with a link to the 
Perinatal Obsessive-Compulsive Scale (POCS), as well as a link to the Edinburgh Postnatal 
Depression Scale (EPDS). 3). A detailed history of use of hormone therapy (e.g. pills, 
patches, implants, etc.) with a focus on (peri-) menopausal women, differentiating between 
physical and psychological symptoms with a link to the Menopause Visual Analogue Scales 
(M-VAS) and to the Greene Climacteric Scale. 4) An iterative module concluding each CIDI 
section to specify the course of mental disorders during the reproductive stages and 
menopausal transition. While retaining core diagnostic sections and diagnostic algorithms, the 
CIDI-V is enriched by women-specific diagnostic modules, providing a wealth of clinically 
relevant information about women’s mental health, not available anywhere else in our current 
psychiatric diagnostic instruments.  
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Introduction: standardized diagnostic interviews for the assessment of mental disorders  
 
Several diagnostic instruments exist for the assessment of mental disorders in clinical and 
epidemiological research. These include the Structured Clinical Interview for DSMIII- R 
(SCID) (Spitzer et al. 1992; Williams et al. 1992), the MINI International Neuropsychiatric 
Interview (M.I.N.I.) (Sheehan et al. 1998); the Schedule for Affective Disorders and 
Schizophrenia (SADS) (Endicott and Spitzer 1978), the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) (van Gülick-Bailer et al. 1995), the Diagnostic Interview Schedule 
(DIS) (Robins et al. 1981), the Present State Examination (PSE) (Wing et al. 1974) and the 
Composite International Diagnostic Interview (CIDI) (Wittchen et al. 2001). The most 
frequently used tool in clinical and community epidemiological studies worldwide is the 
World Health Organization-Composite International Diagnostic Interview (WHO-CIDI) 
(Robins et al. 1988; Wittchen et al. 1991; Wittchen 1994; Kessler and Üstün 2004). Based on 
its predecessor, the DIS, for DSM-III and DSM-III-R (APA 1980, 1987), the CIDI was the 
product of a close collaboration with the authors of the PSE, within the context of 
WHO/ADAMHA Task Force on Diagnostic Classification and Instruments (Lépine et al. 
1993; Semler et al. 1987; Wittchen and Nelson 1996). An attempt was made at the time, to 
cover within one instrument the definitions, criteria and diagnostic algorithms of both the 
ICD-10 (WHO 1993, Diagnostic Criteria for Research) and the DSM-IV (APA 2000). Since 
then several versions, modifications and variants of the CIDI have been developed for use in 
small and large scale epidemiological and clinical studies for lifetime, 12-month and cross-
sectional diagnoses; additionally interval and change- versions for longitudinal research 
became available, supplemented by various additional diagnostic modules (Andrews and 
Wittchen 1995; Cottler et al. 1991; Kessler and Üstün 2004; Kessler et al. 1998a, b, 2000; 
Lachner and Wittchen 1996; Lieb et al. 2000; Rubio-Stipec et al. 1993; Wittchen et al. 1995, 
1998, 1996; Wittchen and Pfister 2004; overview see Wittchen et al. 2001). It is important to 
note that the diagnostic algorithms were retained in all versions, thus allowing for cross-walks 
from earlier to later versions even when changes in the diagnostic system occurred. Divided 
into 16 diagnostic sections, the CIDI allows the fully standardized symptom and syndrome 
assessment of a total of 56 core diagnoses of mental disorders including information regarding 
onset, recency, severity, and impairment as well as patterns of co-morbidity. It offers also 
some crude information about help seeking and health care utilization, and provides data 
about the temporal relationships of syndromes by incorporation of symptom and time-related 
questions for persistence and duration. Symptom questions address problems that the 
respondent has experienced, probing additionally for significance and causation (i.e. 
substance induced/ or due to general medical conditions) as well as for symptoms that have 
occurred in the person’s lifetime or in other time-frames (e.g., past 12 months). Diagnoses of 
mental disorders can be obtained for the corresponding time-frames (current: 2 or 4 weeks, 12 
months, lifetime) by the use of computerized algorithms (Essau and Wittchen 1993). The 
CIDI is a standardized diagnostic interview. The interviewer is instructed to ask all questions 
exactly as written, to code the respective answer of the respondent (interviewers are not 
allowed in the interview to code clinical impression, except for supplementary observational 
items), and to follow the fixed skip rules to enhance efficiency. All interview questions must 
be read exactly as written and the interviewer should not rephrase the question (Kessler and 
Üstün 2004; Wittchen and Semler 1990). The administration is further facilitated by the use of 
a Respondent Booklet, providing a visual presentation of more complex response options, 
symptom lists, and dimensional questionnaires. The CIDI can be administered by non-
clinicians given appropriate standard training. Learning the CIDI requires a training seminar 
of several days up to one week duration for the paper and pencil administration and 2 to 3 
days for the Computer Assisted Personal Interview (CAPI) version. The CIDI is applicable 
for the age groups of 14 to 65 years and for respondents from different cultural and 
educational background (Robins et al. 1988). Respondents with severe intellectual 
disturbances, dementia or acute psychotic states should be excluded on the basis of the 
optional CIDI Mini- Mental Examination module (Wittchen and Pfister 1997).  
 
In summary, the CIDI is easy to administer, available in several languages and has established 
reliability and validity (Andrews and Peters 1998; Essau and Wittchen 1993; Kessler et al. 
1998a, b; Knappe et al. 2008; Lachner et al. 1988; Reed et al. 1998; Spengler and Wittchen 
1988; Wittchen et al. 1989, 1996, 1998, 1999).  
 
The need for a female-specific diagnostic interview  
 
Over the past decade it became increasingly evident, that neither the CIDI nor other standard 
diagnostic interviews provide sufficiently detailed information about female-specific 
disorders, such as PMDD, female-specific characteristics of psychopathological presentations 
such as mental disorders with post-partum onset, the relationship of characteristics of the 
menstrual cycle with psychopathology and peri- and post menopausal manifestations of 
syndromes (Soares and Zitek 2008; Steiner et al. 2003a; Yonkers and McCunn 2007). Given 
the increased psychopathological burden for women associated with most diagnoses (Andrade 
et al. 2003), the lack of such an instrument has also impeded the accumulation of better 
clinical-epidemiological information regarding the core factors associated with the increased 
incidence and prevalence of mental disorders in women. Epidemiological studies consistently 
show that with the onset of the reproductive years at menarche, mood disorders are at least 
twice as common in women than in men (Kessler 2003; Lewinsohn et al. 1998; Steiner et al. 
2003a; Wittchen and Jacobi 2005). A similar gender-specific pattern is also evident in 
anxiety, eating and somatoform disorders as well as with regard to the type and extent of 
comorbid patterns (Escobar et al. 1989; Fairburn and Harrison 2003; Rief et al. 2001; 
Wittchen and Jacobi 2005; Yonkers and McCunn 2007). There is also considerable evidence 
that onset, course, and prognosis of these disorders may be different for men and women 
(Fehm et al. 2005; Wittchen and Jacobi 2005). Due to the fact that almost all epidemiological 
instruments do not address the specific characteristics of women’s reproductive years, it has 
been difficult to relate psychopathological syndromes and their course to core female-specific 
issues, such as the menstrual cycle, pregnancy, postpartum, and menopause (Steiner et al. 
2003a; Yonkers and McCunn 2007). Additionally, some disorders that are exclusively 
relevant to women such as PMDD and Perinatal and Perimenopausal Disorders are not 
covered by the existent standard diagnostic tools. Despite the wide range of instruments 
available that specifically address some of these critical issues, these tools are typically 
questionnaires covering only a few domains and can not easily be embedded into one 
coherent and conceptually sound assessment instrument. Thus, except for some recent 
attempts to supplement the standard CIDI with female-specific diagnostic categories such as 
PMDD (Wittchen et al. 2002), so far—and to our knowledge—there is no instrument covering 
a broader spectrum of women-specific mental disorders.  
 
Designing a female-specific diagnostic interview  
 
In response to this marked deficit, the authors convened a working group to explore existing 
instruments and their suitability for developing a female-specific diagnostic assessment tool. 
The group decided, after careful review of existing evidence, on the following principles:  
 
1. The instrument should be a modification of an existing instrument, rather than a new stand-
alone instrument. This should allow for easy comparison of any newly generated female 
specific data with existing data bases.  
 
2. In-depth psychometric analyses should be performed on all newly-added as well as 
modified modules and sections.  
 
3. The standardized interview approach should be maintained to increase inter-rater reliability 
and to ensure consistency between different research groups and different settings.  
 
4. A lifetime interview approach in addition to cross-sectional data should be used to ensure 
lifetime information about the reproductive cycle. The interview should have established 
reliability and validity with regard to lifetime retrospective information as well as age of 
onset.  
 
5. The utility of the instrument would profit substantially from incorporating dimensional 
aspects (Regier 2007; Shear et al. 2007).  
 
6. The interview should be available in a computerized format (CAPI and diagnostic analysis) 
to avoid costly separate data entry and analysis.  
 
7. Pilot data demonstrating the feasibility of incorporating female-specific questions and 
modules should be available from at least one clinical setting (see Steiner et al. 2008; Rieder 
et al. 2009).  
 
Based on these considerations the group chose the CIDI platform as the most appropriate, 
promising and comprehensive interview available in meeting these requirements. This 
decision was further supported by a number of additional advantages, such as (a) the CIDI is 
modular and flexible allowing easy incorporation of diagnostic and syndromes modules as 
well as questionnaires, (b) the availability of existing training programs and (c) the relative 
ease of reliable administration and analysis. We acknowledged though the well known 
limitations of a non-clinician interview, ie lack of more subtle psychopathological 
differentiations a clinician might be able to code, clinical features and clinical severity ratings. 
Based on these considerations, a series of supplementary additions was designed, incorporated 
into the existing CIDI, and pilot-tested without changing the established skip rules, diagnostic 
modules, and algorithms of the CIDI (Steiner et al. 2008).  
 
The content of the CIDI-VENUS (CIDI-V, Martini et al. 2007a, b; Steiner et al. 2007a, 
b)  
 
Table 1 describes the structure of the standard WHO-CIDI, detailing in which sections what 
type of modular extensions were incorporated.  
 
1. Section A  
 
The rather brief introductory Section (Section A, Demographics) of the CIDI, which 
originally only included crude biosocial and socio-demographic information, was 
supplemented by a series of new questions providing a wide range of female-specific general 
health information, that cuts across all diagnostic categories. This expansion also links initial 
answers to subsequent questions in the interview. For example, if the stem questions for 
menopause are denied, respective questions are skipped later on in the interview (and 
respectively suppressed in the computerized version). This section also includes a 
standardized assessment of the respondents’ menstrual cycle, pregnancy, postpartum period, 
peri- and postmenopause as well as a detailed obstetric and gynaecologic history. The 
questions are partly supported by respondent lists and questionnaires as part of the 
Respondent Booklet (Martini et al. 2007b; Steiner et al. 2007b).  
 
2. Iterative Modules to relate symptoms and disorders to reproductive stages and menopausal 
transition in diagnostic sections  
 
Based on this background information collected in Section A, the subsequent diagnostic 
sections are supplemented by an Iterative Module (see Table 2) to assess the temporal 
association of previously reported symptoms and disorders in each respective Section with 
regard to menstrual cycle, pregnancy, postpartum period, peri- and postmenopause. These 
additional questions at the end of the diagnostic Section allow the determination of how onset, 
course and symptom pattern of the respective syndrome is related to women-specific issues. 
In the mood, anxiety, eating, somatoform and psychotic disorders sections 
(psychopathological syndromes sections) the instrument asks specifically about the associated 
symptoms and their impact (e.g., improvement or worsening, increase or decrease of 
frequency or symptom magnitude) during the different phases of the menstrual cycle and 
during pregnancy, postpartum, and menopausal transition. For substance use disorders (use of 
nicotine, alcohol, drugs) and use of medications (substance use sections) the possible 
teratogenic effects on the offspring were considered in relation to pregnancy and postpartum, 
assessing whether the respondent stopped, reduced or continued substance use during 
pregnancy and breastfeeding (see Table 2).  
 
The Section for Depressive Disorders allows for differentiation of the subtypes of major 
depression including specification of severity (e.g. severe episode with psychotic features).  
 
The Section for Specific Phobias was expanded by questions regarding the strong fear (or 
avoidance) of pregnancy and delivery. Fertile women who prevent a pregnancy despite of the 
desire to have a child were asked about excessive avoidance strategies (e.g., usage of several 
contraception methods), whereas for pregnant women, requested anaesthesia or elective 
caesarean section were considered to be relevant.  
 
The Section of Posttraumatic Stress Disorder is extended by a set of questions concerning the 
occurrence of potentially traumatic events during pregnancy, associated complications during 
gestation or childbirth, and experience of childbirth (incl. subsequent psychopathological 
symptoms). For Eating Disorders additional questions concerning weight gain or weight 
reduction in connection with pregnancy (incl. Hyperemesis Gavidarum), postpartum, and 
menopause were added (see Table 1).  
 
3. Probe flow chart and time-related questions  
 
The inclusion of women-specific issues also made it necessary to amend some of the CIDI-
specific probe questions that are used for specific symptoms and syndromes to exclude 
substance-related and somatic-related factors (Essau and Wittchen 1993; Rubio-Stipec et al. 
1993). Here the instrument allows for an additional specification for serious symptoms which 
are mainly attributed to menstrual cycle, pregnancy, postpartum, or menopause as a specific 
variant of a ‘somatic condition’.  
 
The analysis of a temporal coincidence of psychological symptoms and women-specific 
issues further required the expansion of the CIDI time-related questions (Essau and Wittchen 
1993), allowing now for coding the exact time a particular symptom occurred.  
 
4. Modifications of the Respondent Booklet (Martini et al. 2007b; Steiner et al. 2007b)  
 
The supplementary questions and modules also prompted the need for a considerable 
expansion of the Respondent Booklet and the incorporation of dimensional scales established 
in previous research. In particular we added:  
 
– The Born-Steiner Irritability Scale (B-SIS), (Born et al. 2008) which is a self-rating scale to 
assess irritability, a prominent symptom in the spectrum of female-specific mood disorders 
(Born and Steiner 2000).  
– The Premenstrual Symptoms Screening Tool (PSST), (Steiner et al. 2003b) which was 
developed on the basis of DSM-IV research criteria for the Premenstrual Dysphoric Disorder 
(APA 2000) and reflects these criteria with additional severity ratings.  
– The Edinburgh Postnatal Depression Scale (EPDS) (Cox et al. 1987) as a short, reliable, 
valid and widely and internationally accepted screening questionnaire to assess depression 
and anxiety during pregnancy and the postpartum period.  
– The Greene Climacteric Scale (Greene 1998) as a reliable and valid questionnaire, which 
measures psychological, somatic, and vasomotor menopausal symptoms.  
– The Perinatal Obsessive-Compulsive Scale (POCS) (Lord et al. 2008)  
– The Menopause Visual Analogue Scales (M-VAS) (Steiner et al. 2008) (see Table 1).  
 
Diagnostic analysis and output  
 
Maintaining the integrity of the overall computerized algorithmic platform for the standard 
sections of the CIDI, we expanded the CIDI output that typically only reveals categorical 
diagnostic information (for threshold and subthreshold disorders, core syndromes and 
information about onset, subtype and recency) (Wittchen 1993).  
 
The CIDI-Venus standard output (see Fig. 1) was supplemented by:  
 
– women-specific information regarding the individual gynaecological history (e.g., 
menarche, abdominal operations, and hormonal therapy), – adverse pregnancy outcomes 
(number and dates of abortions, miscarriages, stillbirths, or sudden infant death),  
– number of children and information concerning birth outcomes (e.g., gestational age, birth 
weight and length, duration of childbirth),  
– the PSST and the corresponding decision rules (Steiner et al. 2003b) as well as scoring of 
the EPDS, the Greene Climacteric Scale, the M-VAS, and the POCS (Cox et al. 1987; Greene 
1998; Lord et al. 2008)  
 
The output for each diagnosis shows whether the respondent attributes the beginning or an 
aggravation of the reported psychopathological syndromes to women-specific issues 
(menstrual cycle, pregnancy, postpartum, or menopause). It also provides information about 
termination or reduction in substance use during pregnancy and while breastfeeding.  
 
Conclusion and outlook  
 
The standardized question format of the CIDI-V provides a systematic and comprehensive 
approach to current female-specific core questions in mental disorders and 
psychopathological research, allowing a reliable examination of a wide range of mental 
disorders with embedded modular additions of women-specific conditions and factors 
(menstruation, pregnancy, postpartum, or menopause). The availability of a standardized and 
comprehensive categorical and dimensional examination of mental disorders and 
psychopathological syndromes during pregnancy as well as pregnancy and delivery outcomes 
(e.g., gestational age, mode of delivery) is expected to provide an extensive and solidly 
coordinated basis for cross-sectional and longitudinal studies in epidemiological and clinical 
settings. Linked to the already existent family-genetic CIDI version (Lieb et al. 2000) the 
instrument might also enhance the efficiency and the detail of studies dealing with the familial 
transmission of mental disorders as well as perinatal research in general.  
 
The development of a male-specific CIDI supplement might be a future challenge, aiming a 
more detailed examination of gender-differences as well as an investigation of conditions that 
are more common in men (e.g. ADHD, autism spectrum disorders) (van Engeland and 
Buitelaar 2008; Wittchen and Jacobi 2005).  
 
The CIDI-V was primarily developed for epidemiological studies to examine women-specific 
disorders, but it can also be used for clinical practice. Particularities concerning occurrence 
(prevalence and incidence), maintenance, comorbidity patterns, and temporal relationships 
with the female reproductive cycle may be explored on this basis more comprehensively. The 
CIDI-V utility is enhanced by further covering critical issues like the impact of adverse 
pregnancy outcomes (e.g. stillbirth) and consequences of abdominal operations.  
 
The CIDI-V is available as lifetime and 12-month cross-sectional CAPI as well as paper and 
pencil version in English (Steiner et al. 2007a, b) and German (Martini et al. 2007a, b). The 
psychometric exploration of CIDI-V is currently underway; however one would expect that 
the reliability and validity of diagnostic sections and embedded instruments will not differ 
significantly from those in previous studies, given that only some of the context variables are 
different.  
 
 
Table 1: Sections of the standard WHO-CIDI and women-specific supplements of the CIDI-V (Wittchen 
and Pfister 1997; Martini et al. 200a,b; Steiner et al. 200a,b)  
WHO-CIDI 
Sections 
Supplements: CIDI-V Interview  Supplements: CIDI-V 
Respondent Booklet 
A  Demographics Reproductive history: current pregnancy 
(expected date of delivery, first day of  last 
menstrual period); multiple pregnancy; live births 
(gestational age at birth, birth weight, mode of 
delivery, breastfeeding history); adverse 
pregnancy outcomes (miscarriages, abortion, 
stillbirth, sudden infant death)  
Menstrual history: premenstrual symptoms; 
regularity and duration of a cycle 
Obstetric and gynaecologic history: operations; 
contraceptive history 
Menopausal history: symptoms and causes (e.g., 
surgically induced) of menopause; hormone 
therapy  
- PSST (Steiner et al. 
2003b)  
- M-VAS (Steiner et al. 
2008)  
- Greene Climacteric Scale 
(Greene 1998)  
- List V0: Abdominal 
operation  
- List V1: Indication for 
abdominal operation 
- List V2: Contraception 
methods 
- List V3: Cause of 
amenorrhoea 
- List V4: Menopausal 
symptoms 
C  Somatoform 
disorders 
  
D  Anxiety 
disorders 
- phobic fear of pregnancy 
and delivery and avoidance 
strategies (e.g., elective 
caesarean section) 
- List D71: Fear/ 
avoidance of pregnancy 
and associated 
circumstances 
E  Depressive 
disorders  
F Bipolar 
disorders 
- number of episodes of 
mood problems starting 
during pregnancy and 
postpartum, incl. onset and 
recency 
- EPDS (Cox et al. 1987) 
- B-SIS (Born et al. 2008) 
G  Psychotic 
disorders 
 - List G1: delusions 
pertaining the child  
H  Eating 
Disorders 
- weight gain/loss during 
pregnancy, postpartum, and 
menopause 
- morning sickness and 
Hyperemesis gavidarum 
during pregnancy 
 
K  Obsessive-
compulsive 
disorder 
 
 
 
 
 
 
 
- relation of 
respective 
syndrome 
problems  to 
menstrual cycle 
(luteal phase), 
pregnancy, 
postpartum, 
breastfeeding, 
and peri-/ 
postmenopause 
 - List K1: obsessions 
pertaining the child  
- List K2: compulsions 
pertaining the child  
N  Posttraumatic 
Stress 
Disorder 
- occurrence of significant events during 1st, 2nd, 
or 3rd trimester of pregnancy and associated 
pregnancy and birth complications (e.g., preterm 
delivery) 
- experience of childbirth and questions regarding 
subsequent symptoms of posttraumatic stress 
disorder 
- List N1: traumatic 
experience of childbirth  
B  Nicotine  
I Alcohol  
L Drugs and 
medication 
 
 
- substance consumption during pregnancy and 
breastfeeding; amount per day  
 
 
Table 2: Example for Questions of the Iterative Module in Psychopathological syndromes sections and 
substance use sections  
Iterative Module: Psychopathologic syndromes section 
Menstrual Cycle Were any of these (respective syndrome problems) related to your menstrual 
cycle? Did they get worse before [1], during [2] or after [3] your menstruation 
[code lowest number]? If yes, specify and code, which. 
Pregnancy Did any of these (respective syndrome problems) start while you were pregnant? 
If yes, specify and code which.  
Did any of these (respective syndrome problems) change during pregnancy? 
Overall, while you were pregnant, would you say that these (respective syndrome 
problems) got better [1], worse [3] or remain unchanged [2]? 
Postpartum/ Did any of these (respective syndrome problems) start in the year after having a 
Breastfeeding baby? If yes, specify and code which.  
Did any of these (respective syndrome problems) change in the year after having 
a baby? Overall, in the year after having a baby, would you say that these 
(respective syndrome problems) got better [1], worse [3] or remain unchanged 
[2]? 
Did any of these (respective syndrome problems) start while you were 
breastfeeding? If yes, specify and code which.  
Did any of these (respective syndrome problems) change while you were 
breastfeeding? Overall, while you were breastfeeding, would you say that these 
(respective syndrome problems) got better [1], worse [3] or remain unchanged 
[2]? 
Menopause Did any of these (respective syndrome problems) start when you became peri- or 
postmenopausal? If yes, specify and code, which. 
Did any of these (respective syndrome problems) change when you became peri- 
or postmenopausal? Overall, when you became peri- or postmenopausal, would 
you say that these (respective syndrome problems) got better [1], worse [3] or 
remain unchanged [2]? 
Iterative Module: Substance Use Sections 
Pregnancy Did you (use substance X) when you learned that you are pregnant? Did you 
completely stop/ reduce (using substance X) when you learned that you are 
pregnant? Code type and amount per day. 
Breastfeeding Did you (use substance X) when you were breastfeeding? Did you completely 
stop/ reduce (using substance X) when you were breastfeeding? Code type and 
amount per day. 
Note, questions were partly adapted to the content of the respective section 
 (e.g., asking for severity or frequency instead of or additionally to worsening) 
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